4530 — Hisamitsu Pharmaceutical Co Share News
0.000.00%
- ¥425bn
- ¥312bn
- ¥163bn
Table: Hisamitsu -2017/18 group results
Table: Hisamitsu -2017/18 parent results
Japan's Hisamitsu rises on profit forecast hike
Table: Hisamitsu -2017/18 group forecast
Brief: Hisamitsu Pharmaceutical to set up pharmaceutical import and sales unit in Hong Kong
Table: Hisamitsu - 9-MTH group results
Brief: Noven files patent infringement lawsuit against Alvogen
Table: Hisamitsu - 6-MTH group results
Brief: Hisamitsu Pharmaceutical's operating profit probably shrank 3 percent to 12.5 billion yen - Nikkei
Brief: Hisamitsu Pharmaceutical to set up subsidiary in China
Table: Hisamitsu -Q1 group results
Brief: Hisamitsu Pharmaceutical's sales for March-May qtr seen down 8 pct - Nikkei
Table: Hisamitsu -2016/17 parent results
Table: Hisamitsu -2016/17 group results
Table: Hisamitsu -9-MTH group results
Brief: Hisamitsu Pharmaceutical completes 2 mln shares' repurchase for 11.15 bln yen
Brief: Hisamitsu Pharmaceutical repurchases 840,000 shares in October
Table: Hisamitsu -6-MTH group results
Brief: Hisamitsu Pharmaceutical unit assigns rights for Brisdelle Capsules and Pexeva Tablets